A carregar...
SALL4 Immunoreactivity Predicts Prognosis in Western Hepatocellular Carcinoma Patients but is a Rare Event - A Study of 236 Cases
Prognostic biomarkers that stratify patients with cancer are needed. Recent studies from Asia have implicated SALL4, a stem cell marker, as useful in identifying aggressive cases of hepatocellular carcinoma (HCC), and over 50% of the cases tested had upregulation by microarray or dense immunoreactiv...
Na minha lista:
| Publicado no: | Am J Surg Pathol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5854193/ https://ncbi.nlm.nih.gov/pubmed/24805857 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAS.0000000000000218 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|